News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

CD4 count news

Show

From To
Starting treatment
Gender difference in vital cell count of HIV patients

Male HIV patients in rural South Africa reach the low immunity levels required to become eligible for antiretroviral treatment in less than half the time it takes for immunity levels to drop to similar levels in women, according to new research. Researchers also found a link between potential proxy measures of nutritional status and disease progression, with those reporting food shortages and use of nutritional supplements reaching lower levels of immunity faster.

Published
10 June 2015
From
Science Daily
CD4 count
Annual CD4 count monitoring may be sufficient for people doing well on HIV treatment

Annual CD4 count monitoring may be sufficient for people taking antiretroviral treatment who have a suppressed viral load and a CD4 count above 250 cells/mm3, investigators report

Published
15 April 2015
By
Michael Carter
How HIV works
Researchers may have caught HIV becoming more virulent

A study from Cuba has generated wide media interest because researchers have identified a particular variety of the virus which is associated with rapid post-diagnosis falls in

Published
19 February 2015
By
Gus Cairns
Epidemiology
No improvements in CD4 count at diagnosis in African patients in last decade

A study by Harvard Medical School has found that the average CD4 count in sub-Saharan African people who are diagnosed with HIV has not risen since 2002.

Published
04 February 2015
By
Gus Cairns
Treatment outcomes and life expectancy
Starting HIV treatment early and then interrupting is no better than delaying it

A French study that looked at the total amount of time since infection that people with HIV have spent with a detectable viral load has found that,

Published
22 January 2015
By
Gus Cairns
Treatment outcomes and life expectancy
HIV has become more virulent over time, not less, European study finds

The largest cohort study ever to look at CD4 count and viral loads in HIV-positive people around the time of diagnosis has found evidence that HIV, at

Published
10 December 2014
By
Gus Cairns
Treatment outcomes and life expectancy
Restoring and maintaining a high CD4 count possible for vast majority of people living with HIV in France

A large French study has shown that the vast majority of people living with HIV who started treatment since 2000 in a national cohort achieved a CD4

Published
12 November 2014
By
Alain Volny-Anne
The genetics of coping with HIV

We respond to infections in two fundamental ways. One is 'resistance,' where the body attacks the invading pathogen and reduces its numbers. Another, which is much less well understood, is 'tolerance,' where the body tries to minimize the damage done by the pathogen. A study using data from a large Swiss cohort of HIV-infected individuals gives us a glimpse into why some people cope with HIV better than others.

Published
12 November 2014
From
Science Daily
Access to medicines and treatment
Thai patients to receive free HIV drugs, regardless of CD4 count

The Thai Public Health Ministry has started distributing free antiretroviral drugs to all HIV patients in a move to expand treatment coverage and place them under the state's monitoring system. Previously, HIV patients would receive the drugs only if their number of CD4 cells — which mark the presence of HIV antibodies — decreased to 350, compared with 500 in normal people. From Wednesday, all HIV patients would have access to the drugs without the need for a CD4 count, Deputy Public Health Minister Somsak Chunharas said on Wednesday.

Published
02 October 2014
From
Bangkok Post
Health monitoring in resource-limited settings
Point-of-care CD4 testing is economically feasible for HIV care in resource-limited areas

A study by Massachusetts General Hospital investigators, working in collaboration with colleagues in Mozambique and South Africa, indicates that routine use of point-of-care CD4 testing at the time of HIV diagnosis would be cost effective in countries where health care and other resources are severely limited.

Published
17 September 2014
From
Eurekalert Inf Dis
← Prev12345...12Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.